• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Transparent and complete reporting of surrogate endpoints in trials: the SPIRIT-Surrogate and CONSORT-Surrogate extensions.

作者信息

Manyara Anthony Muchai, Ciani Oriana, Taylor Rod S

机构信息

MRC/CSO Social and Public Health Sciences Unit, School of Health and Well Being, University of Glasgow, Glasgow G12 8TB, UK; Global Health and Ageing Research Unit, Bristol Medical School, University of Bristol, Bristol, UK.

Centre for Research on Health and Social Care Management, SDA Bocconi School of Management, Milan, Italy.

出版信息

Lancet. 2024 Jul 27;404(10450):322-324. doi: 10.1016/S0140-6736(24)01306-0. Epub 2024 Jul 11.

DOI:10.1016/S0140-6736(24)01306-0
PMID:39004089
Abstract
摘要

相似文献

1
Transparent and complete reporting of surrogate endpoints in trials: the SPIRIT-Surrogate and CONSORT-Surrogate extensions.试验中替代终点的透明与完整报告：SPIRIT-替代终点和CONSORT-替代终点扩展版
Lancet. 2024 Jul 27;404(10450):322-324. doi: 10.1016/S0140-6736(24)01306-0. Epub 2024 Jul 11.
2
Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE.用于具有替代主要终点的随机对照试验的 SPIRIT 和 CONSORT 扩展的制定方案：SPIRIT-SURROGATE 和 CONSORT-SURROGATE。
BMJ Open. 2022 Oct 11;12(10):e064304. doi: 10.1136/bmjopen-2022-064304.
3
Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol.范围界定和针对性综述，以支持具有替代主要终点的随机对照试验的 SPIRIT 和 CONSORT 扩展的制定：方案。
BMJ Open. 2022 Oct 13;12(10):e062798. doi: 10.1136/bmjopen-2022-062798.
4
Mixed-methods study to develop extensions to the SPIRIT and CONSORT statements for factorial randomised trials: the Reporting Factorial Trials (RAFT) study.一项混合方法研究，旨在为析因随机试验开发SPIRIT和CONSORT声明的扩展内容：析因试验报告（RAFT）研究。
BMJ Open. 2025 Feb 17;15(2):e082917. doi: 10.1136/bmjopen-2023-082917.
5
Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension.社会和心理干预随机试验的报告：CONSORT-SPI 2018扩展版
Trials. 2018 Jul 31;19(1):407. doi: 10.1186/s13063-018-2733-1.
6
Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).改善临床试验报告和方案中的结果报告：临床试验计划终点报告工具（InsPECT）的研究方案。
Trials. 2019 Mar 6;20(1):161. doi: 10.1186/s13063-019-3248-0.
7
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration.随机对照试验报告中替代终点的报告（CONSORT-Surrogate）：扩展清单及解释和说明。
BMJ. 2024 Jul 9;386:e078524. doi: 10.1136/bmj-2023-078524.
8
Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.儿科临床试验方案和报告中报告项目的建议与证据：两项系统评价
Trials. 2015 Sep 18;16:417. doi: 10.1186/s13063-015-0954-0.
9
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration.随机对照试验方案中替代终点报告（SPIRIT-Surrogate）：扩展清单及说明和阐述。
BMJ. 2024 Jul 9;386:e078525. doi: 10.1136/bmj-2023-078525.
10
Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements.用于制定《SPIRIT 2024声明》和《CONSORT 2024声明》的方法。
J Clin Epidemiol. 2024 May;169:111309. doi: 10.1016/j.jclinepi.2024.111309. Epub 2024 Feb 29.

引用本文的文献

1
Development of START-EDI guidelines for reporting equality, diversity and inclusion in research: a study protocol.制定START-EDI研究平等、多样性和包容性报告指南：一项研究方案
BMJ Open. 2025 Jul 16;15(7):e095778. doi: 10.1136/bmjopen-2024-095778.
2
Protocol Development for Investigator-Sponsored Clinical Studies.研究者发起的临床研究的方案制定
Clin Transl Sci. 2025 May;18(5):e70237. doi: 10.1111/cts.70237.